Supporting you in understanding and prioritizing evidence requirements and planning for generating compelling evidence to support payer decision-making.
If you want to achieve a price that truly reflects the value of your asset, it is vital to have quality evidence of that value. We’ll help you develop an impactful evidence generation plan to underpin your value strategy and resonate with payers around the world.
What we do
Inbeeo puts the strategy back into market access. An important part of that process is turning data – whether from secondary or primary research, databases, early advice, clinical trials, real-world evidence, health-economic models, or anywhere else – into insights which can help you:
Create a payer relevant TPP and value proposition with an evidence base to support it
Develop a briefing book for early scientific advice
Identify payer needs and preferences so you can prioritize evidence requirements in different geographies
Critically appraise and provide recommendations to strengthen your health economic models
Build a plan to generate a robust and compelling set of evidence over time to support your market access strategy
How we do it
We understand and analyze evidence needs
Understanding HTA body policies and trends
Analysis of indications, HTA decisions, HEOR data and more
Developing and testing early payer value narratives
Identification and prioritization of evidence gaps
Strengthening RWE and HEOR functions
The tools we use
Our proprietary custom value assessment framework allows our customers to identify data generation strategies which maximize the value of their asset, highlighting key value drivers and domains. Â
